PALMI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 4.619
AS - Asia 2.475
EU - Europa 2.257
SA - Sud America 306
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.714
Nazione #
US - Stati Uniti d'America 4.399
SG - Singapore 1.058
IT - Italia 597
CN - Cina 482
DE - Germania 330
HK - Hong Kong 329
RU - Federazione Russa 319
BR - Brasile 234
SE - Svezia 214
VN - Vietnam 213
IE - Irlanda 178
CA - Canada 173
UA - Ucraina 123
FR - Francia 109
GB - Regno Unito 104
FI - Finlandia 68
IN - India 68
BD - Bangladesh 45
TR - Turchia 45
NL - Olanda 37
AT - Austria 36
IQ - Iraq 33
ID - Indonesia 30
AR - Argentina 27
KR - Corea 27
MX - Messico 27
ES - Italia 26
PL - Polonia 26
BE - Belgio 24
PK - Pakistan 24
JP - Giappone 19
SA - Arabia Saudita 16
ZA - Sudafrica 15
DK - Danimarca 13
UZ - Uzbekistan 13
CO - Colombia 12
VE - Venezuela 12
CH - Svizzera 11
PH - Filippine 11
JO - Giordania 9
MA - Marocco 8
CL - Cile 7
EC - Ecuador 6
KE - Kenya 6
LB - Libano 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BG - Bulgaria 5
OM - Oman 5
AU - Australia 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
TH - Thailandia 4
TW - Taiwan 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
PA - Panama 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
NO - Norvegia 2
SR - Suriname 2
TN - Tunisia 2
A1 - Anonimo 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BT - Bhutan 1
CM - Camerun 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GY - Guiana 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
Totale 9.704
Città #
Singapore 705
Ann Arbor 554
Ashburn 456
Fairfield 327
Hong Kong 321
Woodbridge 288
Chandler 257
Houston 251
Frankfurt am Main 219
San Jose 215
Dublin 173
Wilmington 137
Milan 133
Seattle 129
New York 128
Toronto 117
Cambridge 116
Jacksonville 116
Dearborn 89
Los Angeles 85
Santa Clara 83
Beijing 76
Chicago 69
Princeton 63
Ho Chi Minh City 55
Nanjing 52
Hanoi 47
Dallas 46
Shanghai 45
The Dalles 41
Council Bluffs 39
Hefei 39
Boardman 38
Lissone 34
São Paulo 34
Vienna 33
Lauterbourg 31
Lawrence 30
Munich 30
Altamura 29
Helsinki 27
Moscow 27
Besana In Brianza 25
Buffalo 23
Brussels 22
Jakarta 22
Seoul 22
Warsaw 22
Nanchang 21
Lachine 18
Rome 18
Denver 16
Orem 16
London 15
San Diego 14
Jinan 13
Amsterdam 12
Montreal 12
Phoenix 12
San Francisco 12
Tashkent 12
Turku 12
Guangzhou 11
Paris 11
Rio de Janeiro 11
Baghdad 10
Mountain View 10
Nuremberg 10
Amman 9
Bologna 9
Chennai 9
Hebei 9
Kunming 9
Tianjin 9
Ankara 8
Brooklyn 8
Brugherio 8
Da Nang 8
Mexico City 8
Perugia 8
Poplar 8
Riyadh 8
Sesto San Giovanni 8
Boston 7
Dhaka 7
Haiphong 7
Johannesburg 7
New Delhi 7
Norwalk 7
Querétaro 7
Turin 7
Zhengzhou 7
Atlanta 6
Belo Horizonte 6
Desio 6
Dong Ket 6
Gap 6
Istanbul 6
Kurume 6
Lappeenranta 6
Totale 6.423
Nome #
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 475
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 442
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 374
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 367
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 328
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 328
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 315
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 312
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 310
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 310
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 307
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 306
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 305
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 302
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 298
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 297
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 288
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 287
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 274
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 273
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 269
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 259
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 258
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 255
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 250
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 246
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 240
A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus 230
TEL/ARG induces cytoskeletal abnormalities in 293T cells 221
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 212
The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells 205
Treatment outcome of CRLF2 -rearranged childhood acute lymphoblastic leukaemia: A comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups 205
Gain-of-function mutations in interleukin-7 receptor-{alpha} (IL7R) in childhood acute lymphoblastic leukemias 188
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis 171
The recombinome of IKZF1 deletions in B-cell precursor ALL 170
Totale 9.877
Categoria #
all - tutte 31.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 0 0 46
2021/2022505 35 58 63 33 45 35 16 35 15 41 40 89
2022/2023992 100 330 88 90 59 133 28 52 63 16 26 7
2023/2024693 30 16 31 48 89 197 128 35 35 15 10 59
2024/20251.395 58 136 87 54 145 44 81 42 156 232 138 222
2025/20263.552 396 143 230 462 546 200 503 162 306 300 202 102
Totale 9.877